Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection

Standard

Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection. / Moris, Lisa; Van den Broeck, Thomas; Tosco, Lorenzo; Van Baelen, Anthony; Gontero, Paolo; Karnes, Robert Jeffrey; Everaerts, Wouter; Albersen, Maarten; Bastian, Patrick J; Chlosta, Piotr; Claessens, Frank; Chun, Felix K; Graefen, Markus; Gratzke, Christian; Kneitz, Burkhard; Marchioro, Giansilvio; Salas, Rafael Sanchez; Tombal, Bertrand; Van Der Poel, Henk; Walz, Jochen Christoph; De Meerleer, Gert; Bossi, Alberto; Haustermans, Karin; Montorsi, Francesco; Van Poppel, Hendrik; Spahn, Martin; Briganti, Alberto; Joniau, Steven.

In: FRONT SURG, Vol. 3, 2016, p. 65.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Moris, L, Van den Broeck, T, Tosco, L, Van Baelen, A, Gontero, P, Karnes, RJ, Everaerts, W, Albersen, M, Bastian, PJ, Chlosta, P, Claessens, F, Chun, FK, Graefen, M, Gratzke, C, Kneitz, B, Marchioro, G, Salas, RS, Tombal, B, Van Der Poel, H, Walz, JC, De Meerleer, G, Bossi, A, Haustermans, K, Montorsi, F, Van Poppel, H, Spahn, M, Briganti, A & Joniau, S 2016, 'Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection', FRONT SURG, vol. 3, pp. 65. https://doi.org/10.3389/fsurg.2016.00065

APA

Moris, L., Van den Broeck, T., Tosco, L., Van Baelen, A., Gontero, P., Karnes, R. J., Everaerts, W., Albersen, M., Bastian, P. J., Chlosta, P., Claessens, F., Chun, F. K., Graefen, M., Gratzke, C., Kneitz, B., Marchioro, G., Salas, R. S., Tombal, B., Van Der Poel, H., ... Joniau, S. (2016). Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection. FRONT SURG, 3, 65. https://doi.org/10.3389/fsurg.2016.00065

Vancouver

Bibtex

@article{05c421d24eb24a9f8e825c6d6b639c3b,
title = "Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection",
abstract = "AIM: To determine the impact of the extent of lymph node invasion (LNI) on long-term oncological outcomes after radical prostatectomy (RP).MATERIAL AND METHODS: In this retrospective study, we examined the data of 1,249 high-risk, non-metastatic PCa patients treated with RP and pelvic lymph node dissection (PLND) between 1989 and 2011 at eight different tertiary institutions. We fitted univariate and multivariate Cox models to assess independent predictors of cancer-specific survival (CSS) and overall survival (OS). The number of positive lymph node (LN) was dichotomized according to the most informative cutoff predicting CSS. Kaplan-Meier curves assessed CSS and OS rates. Only patients with at least 10 LNs removed at PLND were included. This cutoff was chosen as a surrogate for a well performed PNLD.RESULTS: Mean age was 65 years (median: 66, IQR 60-70). Positive surgical margins were present in 53.7% (n = 671). Final Gleason score (GS) was 2-6 in 12.7% (n = 158), 7 in 52% (n = 649), and 8-10 in 35.4% (n = 442). The median number of LNs removed during PLND was 15 (IQR 12-17). Of all patients, 1,128 (90.3%) had 0-3 positive LNs, while 126 (9.7%) had ≥4 positive LNs. Patients with 0-3 positive LNs had significantly better CSS outcome at 10-year follow-up compared to patients with ≥4 positive LNs (87 vs. 50%;p < 0.0001). Similar results were obtained for OS, with a 72 vs. 37% (p < 0.0001) survival at 10 years for patients with 0-3 vs. ≥4 positive LNs, respectively. At multivariate analysis, final GS of 8-10, salvage ADT therapy, and ≥4 (vs. <4) positive LNs were predictors of worse CSS and OS. Pathological stage pT4 was an additional predictor of worse CSS.CONCLUSION: Four or more positive LNs, pathological stage pT4, and final GS of 8-10 represent independent predictors for worse CSS in patients with high-risk PCa. Primary tumor biology remains a strong driver of tumor progression and patients having ≥4 positive LNs could be considered an enriched patient group in which novel treatment strategies should be studied.",
keywords = "Journal Article",
author = "Lisa Moris and {Van den Broeck}, Thomas and Lorenzo Tosco and {Van Baelen}, Anthony and Paolo Gontero and Karnes, {Robert Jeffrey} and Wouter Everaerts and Maarten Albersen and Bastian, {Patrick J} and Piotr Chlosta and Frank Claessens and Chun, {Felix K} and Markus Graefen and Christian Gratzke and Burkhard Kneitz and Giansilvio Marchioro and Salas, {Rafael Sanchez} and Bertrand Tombal and {Van Der Poel}, Henk and Walz, {Jochen Christoph} and {De Meerleer}, Gert and Alberto Bossi and Karin Haustermans and Francesco Montorsi and {Van Poppel}, Hendrik and Martin Spahn and Alberto Briganti and Steven Joniau",
year = "2016",
doi = "10.3389/fsurg.2016.00065",
language = "English",
volume = "3",
pages = "65",
journal = "FRONT SURG",
issn = "2296-875X",
publisher = "Frontiers Media S. A.",

}

RIS

TY - JOUR

T1 - Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection

AU - Moris, Lisa

AU - Van den Broeck, Thomas

AU - Tosco, Lorenzo

AU - Van Baelen, Anthony

AU - Gontero, Paolo

AU - Karnes, Robert Jeffrey

AU - Everaerts, Wouter

AU - Albersen, Maarten

AU - Bastian, Patrick J

AU - Chlosta, Piotr

AU - Claessens, Frank

AU - Chun, Felix K

AU - Graefen, Markus

AU - Gratzke, Christian

AU - Kneitz, Burkhard

AU - Marchioro, Giansilvio

AU - Salas, Rafael Sanchez

AU - Tombal, Bertrand

AU - Van Der Poel, Henk

AU - Walz, Jochen Christoph

AU - De Meerleer, Gert

AU - Bossi, Alberto

AU - Haustermans, Karin

AU - Montorsi, Francesco

AU - Van Poppel, Hendrik

AU - Spahn, Martin

AU - Briganti, Alberto

AU - Joniau, Steven

PY - 2016

Y1 - 2016

N2 - AIM: To determine the impact of the extent of lymph node invasion (LNI) on long-term oncological outcomes after radical prostatectomy (RP).MATERIAL AND METHODS: In this retrospective study, we examined the data of 1,249 high-risk, non-metastatic PCa patients treated with RP and pelvic lymph node dissection (PLND) between 1989 and 2011 at eight different tertiary institutions. We fitted univariate and multivariate Cox models to assess independent predictors of cancer-specific survival (CSS) and overall survival (OS). The number of positive lymph node (LN) was dichotomized according to the most informative cutoff predicting CSS. Kaplan-Meier curves assessed CSS and OS rates. Only patients with at least 10 LNs removed at PLND were included. This cutoff was chosen as a surrogate for a well performed PNLD.RESULTS: Mean age was 65 years (median: 66, IQR 60-70). Positive surgical margins were present in 53.7% (n = 671). Final Gleason score (GS) was 2-6 in 12.7% (n = 158), 7 in 52% (n = 649), and 8-10 in 35.4% (n = 442). The median number of LNs removed during PLND was 15 (IQR 12-17). Of all patients, 1,128 (90.3%) had 0-3 positive LNs, while 126 (9.7%) had ≥4 positive LNs. Patients with 0-3 positive LNs had significantly better CSS outcome at 10-year follow-up compared to patients with ≥4 positive LNs (87 vs. 50%;p < 0.0001). Similar results were obtained for OS, with a 72 vs. 37% (p < 0.0001) survival at 10 years for patients with 0-3 vs. ≥4 positive LNs, respectively. At multivariate analysis, final GS of 8-10, salvage ADT therapy, and ≥4 (vs. <4) positive LNs were predictors of worse CSS and OS. Pathological stage pT4 was an additional predictor of worse CSS.CONCLUSION: Four or more positive LNs, pathological stage pT4, and final GS of 8-10 represent independent predictors for worse CSS in patients with high-risk PCa. Primary tumor biology remains a strong driver of tumor progression and patients having ≥4 positive LNs could be considered an enriched patient group in which novel treatment strategies should be studied.

AB - AIM: To determine the impact of the extent of lymph node invasion (LNI) on long-term oncological outcomes after radical prostatectomy (RP).MATERIAL AND METHODS: In this retrospective study, we examined the data of 1,249 high-risk, non-metastatic PCa patients treated with RP and pelvic lymph node dissection (PLND) between 1989 and 2011 at eight different tertiary institutions. We fitted univariate and multivariate Cox models to assess independent predictors of cancer-specific survival (CSS) and overall survival (OS). The number of positive lymph node (LN) was dichotomized according to the most informative cutoff predicting CSS. Kaplan-Meier curves assessed CSS and OS rates. Only patients with at least 10 LNs removed at PLND were included. This cutoff was chosen as a surrogate for a well performed PNLD.RESULTS: Mean age was 65 years (median: 66, IQR 60-70). Positive surgical margins were present in 53.7% (n = 671). Final Gleason score (GS) was 2-6 in 12.7% (n = 158), 7 in 52% (n = 649), and 8-10 in 35.4% (n = 442). The median number of LNs removed during PLND was 15 (IQR 12-17). Of all patients, 1,128 (90.3%) had 0-3 positive LNs, while 126 (9.7%) had ≥4 positive LNs. Patients with 0-3 positive LNs had significantly better CSS outcome at 10-year follow-up compared to patients with ≥4 positive LNs (87 vs. 50%;p < 0.0001). Similar results were obtained for OS, with a 72 vs. 37% (p < 0.0001) survival at 10 years for patients with 0-3 vs. ≥4 positive LNs, respectively. At multivariate analysis, final GS of 8-10, salvage ADT therapy, and ≥4 (vs. <4) positive LNs were predictors of worse CSS and OS. Pathological stage pT4 was an additional predictor of worse CSS.CONCLUSION: Four or more positive LNs, pathological stage pT4, and final GS of 8-10 represent independent predictors for worse CSS in patients with high-risk PCa. Primary tumor biology remains a strong driver of tumor progression and patients having ≥4 positive LNs could be considered an enriched patient group in which novel treatment strategies should be studied.

KW - Journal Article

U2 - 10.3389/fsurg.2016.00065

DO - 10.3389/fsurg.2016.00065

M3 - SCORING: Journal article

C2 - 28018903

VL - 3

SP - 65

JO - FRONT SURG

JF - FRONT SURG

SN - 2296-875X

ER -